D. Bell

发表

Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

D. Stablein, H. Dupont, G. Glenn, 2014, The Lancet. Infectious diseases.

Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.

A. Pawłowski, B. Johansson‐Lindbom, D. Bell, 2021, Vaccine.

A double‐blind, placebo‐controlled, randomised, parallel‐group, dose‐escalating, repeat dose study in healthy volunteers to evaluate the safety, tolerability, pharmacodynamic effects and pharmacokinetics of the once daily rectal application of NRL001 suppositories for 14 days

C. Pediconi, D. Bell, H. Gruss, 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Randomised clinical trial: study of escalating doses of NRL001 given in rectal suppositories of different weights

C. Pediconi, D. Bell, A. Jacobs, 2014, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Pharmacodynamics and safety of the novel selective progesterone receptor modulator vilaprisan: a double-blind, randomized, placebo-controlled phase 1 trial in healthy women.

M. Schultze-Mosgau, B. Rohde, C. Seitz, 2016, Human reproduction.

Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—delayed add-back onset does not improve bleeding pattern

J. Gotteland, O. Pohl, D. Bell, 2020, Reproductive Sciences.

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

M. Buti, M. Biermer, T. Asselah, 2023, The Lancet Gastroenterology & Hepatology.